FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 無錫藥明康德新藥開發股份有限公司 呈交日期： 2025年7月11日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 A | | 於香港聯交所上市 | 否 | | | 證券代號 (如上市) | | 說明 | 於上海證券交易所上市 | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 ...

Market Overview - The Hong Kong stock market showed a volatile upward trend in the morning, with the Hang Seng Index and the Hang Seng China Enterprises Index both rising over 1% at one point. By the close, the Hang Seng Index increased by 0.46% to 24139.57 points, with a total trading volume of 3239.5 billion HKD. For the week, the Hang Seng Index rose by 0.93% [1] - The current dollar index is under pressure due to crowded short positions and cooling interest rate cut expectations, which poses risks to the Hong Kong market. The fundamentals and sentiment indicators for Hong Kong stocks are weakening, with increased competition in the food delivery sector and a weakening AI narrative affecting the Hang Seng Technology Index [1] Blue Chip Performance - WuXi AppTec (02359) led the blue-chip stocks, closing up 10.46% at 88.15 HKD, contributing 4.53 points to the Hang Seng Index. The company issued a profit warning, expecting a revenue of approximately 20.799 billion RMB for the first half of 2025, a year-on-year increase of about 20.64%, and a net profit of 8.561 billion RMB, a year-on-year increase of about 101.92% [2][5] - Other blue-chip stocks included WuXi Biologics (02269) up 3.7%, Hong Kong Exchanges and Clearing (00388) up 2.95%, while China Merchants Bank (03968) and China Resources Mixc Lifestyle (01209) saw declines [2] Sector Highlights - Large technology stocks mostly rose, with Alibaba up 1.84% and Meituan up 1.18%. The biopharmaceutical sector saw significant gains, particularly in the CRO segment, with multiple stocks rising over 10% following WuXi AppTec's positive earnings forecast [3] - Brokerage stocks experienced a collective surge, with South China Financial (00619) up 100.89%, and Zhongzhou Securities (01375) up 47.47%, driven by expectations of virtual asset licenses [3][4] Cryptocurrency and Regulatory Developments - The Hong Kong Special Administrative Region's "Stablecoin Regulation" will take effect on August 1, 2025, allowing certain brokerages to provide virtual asset trading services to professional investors. This has generated significant market interest and may enhance the pricing attractiveness of the securities sector [4] - Bitcoin prices surged over 6%, reaching a new high of 117,919 USD, with other cryptocurrencies also rising. The U.S. House of Representatives has designated the week of July 14 as "Cryptocurrency Week" to discuss new regulatory frameworks [6] Steel and Semiconductor Sectors - The steel sector saw early gains, with Chongqing Steel (01053) up 4.08% and Maanshan Steel (00323) up 3.74%. Analysts suggest that ongoing "anti-involution" policies may improve the supply-demand dynamics in the steel industry [7] - Semiconductor stocks were active, with Hua Hong Semiconductor (01347) up 4.12% and SMIC (00981) up 2.22%. TSMC reported a revenue of 263.71 billion NTD for June, a decrease of 17.7% month-on-month but a 26.9% increase year-on-year [8] Notable Stock Movements - Xirui (02507) reached a new high, closing up 14.01% at 48 HKD, driven by developments in the general aviation sector [9] - NIO-SW (09866) rose 5.98% to 29.25 HKD following the announcement of its new product launch [11] - Gold stocks, particularly Laopu Gold (06181), faced significant declines, dropping 11.42% after a recent high [13][14]

Market Overview - The market experienced a high and then a pullback, with the three major indices showing slight increases. The trading volume reached 1.74 trillion, an increase of over 220 billion compared to the previous day [1] - The rare earth magnetic materials sector saw significant gains, with multiple stocks hitting the daily limit, including Northern Rare Earth and Baogang Co. [1][4] - Broker stocks collectively strengthened, with Zhongyin Securities and Zhongyuan Securities also hitting the limit [1] - Stablecoin concepts remained active, with stocks like Guoao Technology and Jinzhen Co. reaching the daily limit [1] - CRO concept stocks performed well, with WuXi AppTec hitting the limit [1] Key Highlights Rare Earth Magnetic Materials - The rare earth magnetic materials sector surged, with stocks like Jingyuntong and Northern Rare Earth achieving consecutive limit-ups. Baogang Co. and Huayang New Materials also saw limit-ups [4] - On July 10, Northern Rare Earth and Baogang Co. announced an adjustment in the third-quarter rare earth concentrate related transaction price to 19,109 yuan/ton, a 1.5% increase from the second quarter's 18,825 yuan/ton [4] - Northern Rare Earth released a performance forecast, expecting a net profit attributable to shareholders of 900 million to 960 million yuan for the first half of 2025, representing a year-on-year increase of 1,882.54% to 2,014.71% [4] RWA (Real World Assets) - The RWA concept was active again, with Huamei Holdings achieving four consecutive limit-ups and Greenland Holdings hitting two consecutive limit-ups [6] - The Shanghai State-owned Assets Supervision and Administration Commission held a study session on the development trends and response strategies for cryptocurrencies and stablecoins [6][8] - RWA on-chain asset scale grew from less than 200 million USD in 2020 to over 23 billion USD, with predictions that it will exceed 2 trillion USD by 2030 [8] Financial Sector - The financial sector showed strong performance, with Nanhua Futures achieving three consecutive limit-ups and Zhongyin Securities hitting two consecutive limit-ups [9] - Recent trading volumes in A-shares have consistently surpassed 1 trillion [9] - The sustainability of the brokerage sector's performance depends on the pace of policy benefits and market activity levels [10][11] Other Active Sectors - Other active sectors included innovative drugs, real estate, and robotics, while new urbanization and electricity sectors faced declines [12]

FF305 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 A | | 於香港聯交所上市 | 否 | | | 證券代號 (如上市) | | 說明 | 於上海證券交易所上市 | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | 於下列日期開始時的結存(註1) | 2025年7月10日 | 2,485,141,055 | | 0 | | 2,485,141,055 | | 1). 其他 (請註明) | | | % | | | | | 參見B部 | | | | | | | | 變動日期 | 2025年7月11日 | | | | | | | 於下列日期結束時的結存 (註5及6) | ...

Group 1 - The Hang Seng Index closed up by 0.46%, while the Hang Seng Tech Index rose by 0.61% [1] - Chinese brokerage stocks strengthened, with Zhongzhou Securities (01375.HK) surging by 47% [1] - The biopharmaceutical sector saw a significant rebound, with WuXi AppTec (02359.HK) increasing by 10% [1] Group 2 - Sectors such as chips, insurance, and cryptocurrency experienced notable gains [1]

Core Viewpoint - The healthcare ETF, Taikang (159760), has shown a strong performance with a 1.51% increase, marking three consecutive days of gains, driven by significant rises in key stocks such as WuXi AppTec and Kelun Pharmaceutical [1][2]. Group 1: ETF Performance - As of July 11, 2025, the Taikang healthcare ETF reached a new high of 82.42 million yuan, the highest in three months [2]. - The index it tracks, the National Public Health and Healthcare Index (980016), rose by 1.45% [1]. Group 2: Company Performance - WuXi AppTec (603259) reported an expected adjusted net profit of approximately 6.315 billion yuan for the first half of the year, a year-on-year increase of about 44.43% [2]. - The company anticipates a net profit attributable to shareholders of approximately 8.561 billion yuan, reflecting a year-on-year growth of about 101.92% [2]. - Basic earnings per share are projected to be around 3.01 yuan, up approximately 106.16% year-on-year [2]. Group 3: Policy and Market Trends - The National Healthcare Security Administration has initiated a new round of adjustments to the national medical insurance drug catalog, indicating a favorable policy environment for innovative drugs [3]. - China ranks first globally in the number of original drugs developed by its enterprises, with increasing foreign capital investment in Chinese innovative drugs [3]. - The healthcare sector is expected to benefit from a comprehensive policy support system, enhancing the global market position of domestic innovative drugs [3]. Group 4: Index Composition - As of May 30, 2025, the top ten weighted stocks in the National Public Health and Healthcare Index accounted for 52.46% of the index, including major players like Hengrui Medicine and Mindray Medical [4].

Market Overview - The three major A-share indices continued to rise, with the Shanghai Composite Index up 0.01% to 3510 points, the Shenzhen Component Index up 0.61%, and the ChiNext Index up 0.8% [1] - Total trading volume reached 1.74 trillion yuan, an increase of 221.5 billion yuan compared to the previous trading day, with over 2900 stocks rising across the market [1] Sector Performance - The rare earth sector saw significant gains, with major companies announcing price increases for rare earth concentrates, leading to a surge in related stocks such as China Rare Earth and San Chuan Wisdom [2][4] - The shipbuilding sector also performed well, with Guorui Technology hitting a 20% limit up [2] - The brokerage sector showed strength, with stocks like Bank of China Securities and Harbin Investment Securities reaching their daily limit [2][6] - Other sectors with notable gains included the import expo, virtual robots, CRO, and digital currency [2] Notable Stocks - Rare earth permanent magnet stocks experienced a strong rally, with Benlang New Materials hitting the daily limit with a 29.95% increase, and other stocks like San Chuan Wisdom and Jiu Wu Gao Ke also reaching their limits [4][5] - In the brokerage sector, Bank of China Securities rose by 10.04%, while Harbin Investment Securities and Zhongyuan Securities also saw significant increases [6][7] - The real estate sector was active, with stocks like Shibei High-tech and Tianbao Infrastructure hitting their limits, indicating a recovery in the real estate market [8] Biopharmaceutical Sector - The biopharmaceutical sector, including innovative drugs and CRO, showed strong performance with stocks like Kailai Ying and WuXi AppTec hitting their limits [9][10] - WuXi AppTec reported a pre-profit of 8.561 billion yuan for the first half of the year, a year-on-year increase of 101.92%, indicating strong growth despite global trade challenges [10][11] Banking Sector - The banking sector faced a decline in the afternoon, with over 20 banks, including Zhejiang Merchants Bank and Shanghai Pudong Development Bank, dropping more than 2% [12][13] Future Outlook - The current average P/E ratio of the Shanghai Composite and ChiNext indices is at a median level over the past three years, suggesting a suitable environment for medium to long-term investments [14] - The Federal Reserve's interest rate decisions may impact global risk appetite, and there is a focus on sectors such as finance, non-ferrous metals, real estate, and photovoltaic equipment for potential investment opportunities [14]

Core Viewpoint - The market experienced a slight increase with the three major indices showing small gains, while trading volume reached a new high since March 15, indicating increased investor activity [1][2]. Market Performance - The Shanghai Composite Index rose by 0.01%, the Shenzhen Component Index increased by 0.61%, and the ChiNext Index gained 0.8% [2]. - The total trading volume in the Shanghai and Shenzhen markets was 1.71 trillion, an increase of 218 billion compared to the previous trading day [1]. Sector Performance - The rare earth permanent magnet sector saw a collective surge, with over 10 stocks, including Northern Rare Earth, hitting the daily limit [1]. - Brokerage and internet finance stocks also experienced a significant rise, with the stock of Zhina Compass reaching an all-time high [1]. - The CRO (Contract Research Organization) sector was active, highlighted by WuXi AppTec's stock hitting the daily limit [1]. - In contrast, bank stocks faced a decline in the afternoon session, with over 20 stocks dropping more than 2% [1]. Overall Market Sentiment - The market displayed a mixed sentiment with more than 2900 stocks rising, indicating a generally positive outlook despite some sector-specific declines [1].

Group 1 - The core viewpoint highlights the strong performance of the innovative drug ETF (560900), which saw a more than 2% increase in intraday trading, with significant trading volume and a notable rise in the underlying index [1] - The innovative drug ETF (560900) has shown impressive growth, with a weekly increase leading among comparable funds, and a substantial rise in both scale and shares over the past three months and six months [1] - WuXi AppTec's half-year performance forecast indicates a revenue of approximately 20.8 billion yuan, a year-on-year growth of about 20.64%, and a net profit attributable to shareholders of around 8.6 billion yuan, reflecting a significant year-on-year increase of approximately 101.92% [1] Group 2 - The trend of Chinese innovative drugs going global is accelerating, with the total value of License-out transactions expected to exceed $43 billion in 2024, accounting for nearly 20% of the global market [2] - The current overseas expansion models include "building ships" (self-declaration for overseas listing) and "borrowing ships" (outsourcing or establishing NewCo), with successful examples like BeiGene's Zebrutinib and Legend Biotech's Cilta-cel [2] - The total value of outbound licensing transactions reached $51.9 billion in 2024, with $48.4 billion disclosed in the first half of 2025, indicating a robust growth trajectory for Chinese innovative drugs [2] Group 3 - Morgan Asset Management is integrating its "Global Vision Investment Technology" product line to assist investors in seizing investment opportunities in quality technology companies amid a new wave of technological advancements driven by AI [2] - Various actively managed funds focus on emerging industry trends, including the Morgan Emerging Power Fund, which aims to capture opportunities in new industries, and the Morgan Smart Connectivity Fund, which targets AI-related sectors [3] - Passive investment options include the Morgan Hang Seng Technology ETF and the Morgan China Innovation Drug Industry ETF, providing investors with easy access to technology and innovative drug sectors [3]

Core Viewpoint - The market is experiencing a significant upward trend, with major indices and a large number of stocks showing strong performance, indicating the onset of a bull market [1] Group 1: Bull Market Indicators - The Shanghai Composite Index and the ChiNext Index both rose over 1%, with more than 2800 stocks in the market increasing in value [1] - The total trading volume in the Shanghai and Shenzhen markets reached 1.02 trillion, an increase of 93.7 billion compared to the previous trading day [1] Group 2: Financial Sector Performance - The brokerage sector saw substantial gains, with stocks like Zhongyin Securities and Hatou Co. hitting the daily limit, while others like Guosheng Financial and Citic Securities rose over 5% [3][5] - The internet finance concept stock, Zhihui, surged over 14%, indicating strong investor interest in this sector [5] Group 3: Innovative Drug Sector - The innovative drug sector continued its strong performance, with stocks like WuXi AppTec and Boteng Co. hitting the daily limit, and others like Changshan Pharmaceutical and Kailai Ying also showing significant gains [9] - WuXi AppTec announced an expected net profit of approximately 8.561 billion, a year-on-year increase of about 101.92% [11] Group 4: Rare Earth Sector Surge - The rare earth permanent magnet sector rose over 6%, with stocks like Benlang New Materials and San Chuan Wisdom hitting the daily limit [13] - Northern Rare Earth announced an adjustment in its rare earth concentrate trading price, which is expected to further boost its profitability, with a projected net profit of 900 million to 960 million, a year-on-year increase of 1882.54% to 2014.71% [16]